QuantumScape Corp Chief Development Officer Mohit Singh filed a Form 4 on November 6, 2026, disclosing a grant of 478,468 restricted stock units at a price of $0.00 on November 4, 2026.
Director Richard Andrew filed an initial statement of beneficial ownership with the SEC on November 6, 2026, disclosing that he held no securities of Knight-Swift Transportation Holdings Inc. as of his appointment date of November 4, 2026.
Luca Giovanni Fasoli, Chief Operating Officer of QuantumScape Corp, filed a Form 4 on November 6, 2026, disclosing the acquisition of 598,086 restricted stock units on November 4, 2026, at no cost.
Director Joshua Hug of Remitly Global, Inc. filed a Form 4 on November 6, 2026, disclosing the sale of a combined 11,000 shares of common stock across two transactions on November 5 and November 6, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Reza Kasnavi, EVP, Chief Ops & Tech Officer at Skyworks Solutions, Inc. (NASDAQ:SWKS), filed a Form 4 on November 6, 2026, disclosing multiple transactions in the company's common stock dated November 5, 2026, including the vesting of restricted stock units, the issuance of performance …
Aeva Technologies, Inc. Chief Executive Officer Soroush Salehian Dardashti filed a Form 4 on November 6, 2026, disclosing the automatic sale of 42,262 shares of common stock on November 5, 2026, to cover tax withholding obligations upon the settlement of restricted stock unit awards.
Aeva Technologies, Inc. Chief Technology Officer and Director Mina Rezk filed a Form 4 on November 6, 2026, disclosing the automatic sale of 28,173 shares of common stock on November 5, 2026, to cover tax withholding obligations upon the settlement of time-based restricted stock …
Director Vyacheslav Kim of Joint Stock Co Kaspi.kz filed a Form 4 on November 6, 2026, disclosing the sale of American Depositary Shares across eleven transactions conducted between November 4 and November 6, 2026, pursuant to a Rule 10b5-1 plan.
Philip G. Brace, CEO and President of Skyworks Solutions, Inc., filed a Form 4 on November 6, 2026, reporting multiple transactions in the company's common stock on November 5, 2026, including the vesting of restricted stock units and the issuance of shares under a …
Steven D. Conly, Senior Vice President, Waters Biosciences at Waters Corp /DE/, filed an initial statement of beneficial ownership (Form 3) on November 6, 2026, reporting securities held as of the event date of October 29, 2026.